Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12749]

Checkpoint inhibitor response prediction milestone using patient-derived ex vivo spheroids

Checkpoint inhibitor response prediction milestone using patient-derived ex vivo spheroids

HERO project aims to help central European haematology patients during COVID-19

HERO project aims to help central European haematology patients during COVID-19

Research leads to better understanding of the immune system in kidney cancer

Research leads to better understanding of the immune system in kidney cancer

$FDA approves tivozanib for relapsed or refractory advanced renal cell carcinoma$

FDA approves tivozanib for relapsed or refractory advanced renal cell carcinoma

Conquering cancer: Global strategy for the elimination of cervical cancer

Conquering cancer: Global strategy for the elimination of cervical cancer

New spherical nucleic acid 'drug' kills tumour cells in humans with glioblastoma

New spherical nucleic acid 'drug' kills tumour cells in humans with glioblastoma

Lower dose, less toxic radiopharmaceutical produces better outcomes

Lower dose, less toxic radiopharmaceutical produces better outcomes

Evidence review examines both benefits and harms for lung cancer screening

Evidence review examines both benefits and harms for lung cancer screening

Experts recommend shared patient - doctor decision-making prior to lung cancer screening

Experts recommend shared patient - doctor decision-making prior to lung cancer screening

Study finds increased risk of death among breast cancer patients who drink sugar-sweetened soda

Study finds increased risk of death among breast cancer patients who drink sugar-sweetened soda

More from ecancer